Cytoplasmic polyadenylation element-binding protein 4 (CPEB4), a zinc-finger-containing sequence-specific RNA-binding protein, has been associated with tumor proliferation, invasion, and migration. Expression of CPEB4 and its prognostic significance in human colorectal cancer (CRC) have not been studied. The aim of the present study was to investigate expression of CPEB4 and its prognostic significance in CRC. Expression of CPEB4 in CRC tissues from two independent cohorts was examined by immunohistochemistry. Prognostic significance was analyzed using receiver operating characteristic curve analysis, Kaplan-Meier curves, and Cox regression analysis. High expression of CPEB4 was observed in 14.8 % of CRCs in the training cohort and 12.2 % of CRCs in the validation cohort. High expression of CPEB4 was significantly correlated with the pM classification, TNM stage, and poorer overall survival in both cohorts. Through multivariate Cox regression analysis, high expression of CPEB4 was found to be an independent prognostic biomarker for overall survival in CRC patients. High expression of CPEB4 may be an independent and useful biomarker for predicting the poor survival of patients with CRC.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63:11–30. doi:10.3322/caac.21166
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90. doi:10.3322/caac.20107
Chen W, Zheng R, Zhang S, Zhao P, Zeng H, Zou X, He J (2014) Annual report on status of cancer in China, 2010. Chin J Cancer Res 26:48–58. doi:10.3978/j.issn.1000-9604.2014.01.08
Dai Z, Zheng RS, Zou XN, Zhang SW, Zeng HM, Li N, Chen WQ (2012) Analysis and prediction of colorectal cancer incidence trend in China. Zhonghua Yu Fang Yi Xue Za Zhi 46:598–603
Center MM, Jemal A, Smith RA, Ward E (2009) Worldwide variations in colorectal cancer. CA Cancer J Clin 59:366–378. doi:10.3322/caac.20038
Edwards BK, Ward E, Kohler BA, Eheman C, Zauber AG, Anderson RN, Jemal A, Schymura MJ, Lansdorp-Vogelaar I, Seeff LC, van Ballegooijen M, Goede SL, Ries LA (2010) Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 116(3):544–573. doi:10.1002/cncr.24760
Mitry E, Rachet B, Quinn MJ, Cooper N, Coleman MP (2008) Survival from cancer of the rectum in England and Wales up to 2001. Br J Cancer 99(Suppl 1):S30–S32. doi:10.1038/sj.bjc.6604579
Brenner H, Bouvier AM, Foschi R, Hackl M, Larsen IK, Lemmens V, Mangone L, Francisci S (2012) Progress in colorectal cancer survival in Europe from the late 1980s to the early twenty-first century: the EUROCARE study. Int J Cancer 131:1649–1658. doi:10.1002/ijc.26192
Wu XR, He XS, Chen YF, Yuan RX, Zeng Y, Lian L, Zou YF, Lan N, Wu XJ, Lan P (2012) High expression of CD73 as a poor prognostic biomarker in human colorectal cancer. J Surg Oncol 106:130–137. doi:10.1002/jso.23056
Zou Y, Chen Y, Wu X, Yuan R, Cai Z, He X, Fan X, Wang L, Wu X, Lan P (2013) CCL21 as an independent favorable prognostic factor for stage III/IV colorectal cancer. Oncol Rep 30:659–666. doi:10.3892/or.2013.2533
Mayr C, Hemann MT, Bartel DP (2007) Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 315:1576–1579
Lee YS, Dutta A (2007) The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev 21:1025–1030
Pique M, Lopez JM, Foissac S, Guigo R, Mendez R (2008) A combinatorial code for CPE-mediated translational control. Cell 132:434–448. doi:10.1016/j.cell.2007.12.038
Belloc E, Mendez R (2008) A deadenylation negative feedback mechanism governs meiotic metaphase arrest. Nature 452:1017–1021. doi:10.1038/nature06809
Eliscovich C, Peset I, Vernos I, Mendez R (2008) Spindle-localized CPE-mediated translation controls meiotic chromosome segregation. Nat Cell Biol 10:858–865. doi:10.1038/nrclinonc.2010.9-c1
Sonenberg N, Hinnebusch AG (2009) Regulation of translation initiation in eukaryotes: mechanisms and biological targets. Cell 136:731–745. doi:10.1016/j.cell.2009.01.042
Silvera D, Formenti SC, Schneider RJ (2010) Translational control in cancer. Nat Rev Cancer 10:254–266. doi:10.1038/nrc2824
Novoa I, Gallego J, Ferreira PG (2010) Mendez R (2009) mitotic cell-cycle progression is regulated by CPEB1 and CPEB4-dependent translational control. Nat Cell Biol 12:447–456. doi:10.1038/ncb2046
Groppo R, Richter JD Translational control from head to tail. Curr Opin Cell Biol 21:444–451. doi:10.1016/j.ceb.2009.01.011
Mendez R, Richter JD (2001) Translational control by CPEB: a means to the end. Nat Rev Mol Cell Biol 2:521–529
Huang YS, Kan MC, Lin CL, Richter JD (2006) CPEB3 and CPEB4 in neurons: analysis of RNA-binding specificity and translational control of AMPA receptor GluR2 mRNA. EMBO J 25:4865–4876
Groisman I, Ivshina M, Marin V, Kennedy NJ, Davis RJ, Richter JD (2006) Control of cellular senescence by CPEB. Genes Dev 20:2701–2712
Richter JD (2007) CPEB: a life in translation. Trends Biochem Sci 32:279–285
Burns DM, Richter JD (2008) CPEB regulation of human cellular senescence, energy metabolism, and p53 mRNA translation. Genes Dev 22:3449–3460. doi:10.1101/gad.1697808
Igea A, Mendez R (2010) Meiosis requires a translational positive loop where CPEB1 ensues its replacement by CPEB4. EMBO J 29:2182–2193. doi:10.1038/emboj.2010.111
Ortiz-Zapater E, Pineda D, Martinez-Bosch N, Fernandez-Miranda G, Iglesias M, Alameda F, Moreno M, Eliscovich C, Eyras E, Real FX, Mendez R, Navarro P (2012) Key contribution of CPEB4-mediated translational control to cancer progression. Nat Med 18:83–90. doi:10.1038/nm.2540
Xu H, Liu B (2013) CPEB4 is a candidate biomarker for defining metastatic cancers and directing personalized therapies. Med Hypotheses 81:875–877. doi:10.1016/j.mehy.2013.08.030
Battifora H (1986) The multitumor (sausage) tissue block: novel method for immunohistochemical antibody testing. Lab Investig 55:244–248
Lin HX, Qiu HJ, Zeng F, Rao HL, Yang GF, Kung HF, Zhu XF, Zeng YX, Cai MY, Xie D (2013) Decreased expression of Beclin 1 correlates closely with Bcl-xL expression and poor prognosis of ovarian carcinoma. PLoS One 8:e60516. doi:10.1371/journal.pone.0060516
Zlobec I, Steele R, Terracciano L, Jass JR, Lugli A (2007) Selecting immunohistochemical cut-off scores for novel biomarkers of progression and survival in colorectal cancer. J Clin Pathol 60:1112–1116
Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pages C, Tosolini M, Camus M, Berger A, Wind P, Zinzindohoue F, Bruneval P, Cugnenc PH, Trajanoski Z, Fridman WH, Pages F (2006) Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313:1960–1964
Huang Y, Li W, Chu D, Zheng J, Ji G, Li M, Zhang H, Wang W, Du J, Li J (2011) Overexpression of matrix metalloproteinase-21 is associated with poor overall survival of patients with colorectal cancer. J Gastrointest Surg 15:1188–1194. doi:10.1007/s11605-011-1519-5
Lin KY, Tai C, Hsu JC, Li CF, Fang CL, Lai HC, Hseu YC, Lin YF, Uen YH (2011) Overexpression of nuclear protein kinase CK2 alpha catalytic subunit (CK2alpha) as a poor prognosticator in human colorectal cancer. PLoS One 6:e17193. doi:10.1371/journal.pone.0017193
Lin AY, Chua MS, Choi YL, Yeh W, Kim YH, Azzi R, Adams GA, Sainani K, van de Rijn M, So SK, Pollack JR (2011) Comparative profiling of primary colorectal carcinomas and liver metastases identifies LEF1 as a prognostic biomarker. PLoS One 6:e16636. doi:10.1371/journal.pone.0016636
Salama P, Phillips M, Grieu F, Morris M, Zeps N, Joseph D, Platell C, Iacopetta B (2009) Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer. J Clin Oncol 27:186–192. doi:10.1200/JCO.2008.18.7229
Nosho K, Baba Y, Tanaka N, Shima K, Hayashi M, Meyerhardt JA, Giovannucci E, Dranoff G, Fuchs CS, Ogino S (2010) Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review. J Pathol 222:350–366. doi:10.1002/path.2774
Kan MC, Oruganty-Das A, Cooper-Morgan A, Jin G, Swanger SA, Bassell GJ, Florman H, van Leyen K, Richter JD (2010) CPEB4 is a cell survival protein retained in the nucleus upon ischemia or endoplasmic reticulum calcium depletion. Mol Cell Biol 30:5658–5671. doi:10.1128/MCB.00716-10
Tian Q, Liang L, Ding J, Zha R, Shi H, Wang Q, Huang S, Guo W, Ge C, Chen T, Li J, He X (2012) MicroRNA-550a acts as a pro-metastatic gene and directly targets cytoplasmic polyadenylation element-binding protein 4 in hepatocellular carcinoma. PLoS One 7:e48958. doi:10.1371/journal.pone.0048958
Huang S, Liao Q, Li L, Xin D (2014) PTTG1 inhibits SMAD3 in prostate cancer cells to promote their proliferation. Tumour Biol 35(7):6265–6270. doi:10.1007/s13277-014-1818-z
This study was approved by the IRB of the Sixth Affiliated Hospital and Cancer Center, Sun Yat-sen University.
Conflict of interest
The authors declare that they have no conflict of interest.
Declaration of funding interests
This work is Supported by the National Natural Science Foundation of China (81,400,604 and 81,402,412).
Xiaosheng He, Xutao Lin, and MuYan Cai contributed equally to this paper.
About this article
Cite this article
He, X., Lin, X., Cai, M. et al. High expression of cytoplasmic polyadenylation element-binding protein 4 correlates with poor prognosis of patients with colorectal cancer. Virchows Arch 470, 37–45 (2017). https://doi.org/10.1007/s00428-016-2037-3
- Colorectal cancer
- Cytoplasmic polyadenylation element-binding proteins